Code Bio
Katelin Decker began their professional career in 2016 as a Program Leader at Carson Simpson Christian Farm. In 2017, they joined Panera Bread as a Zone Leader. In 2019, they began working at Arcadia University as a Biomedical Laboratory Research Assistant and Laboratory Assistant. In this role, they conducted research, trained undergraduates, authored their undergraduate thesis, and contributed to two papers to be published. In 2020, they joined CVS Health as a Shift Supervisor RX. In 2022, they began their current role as a Molecular Biochemist (Research & Development) at Code Biotherapeutics.
Katelin Decker graduated from Arcadia University in 2022 with a Bachelor of Science in Biology/Biological Sciences, Molecular Biology & Biochemistry. Katelin began their studies in 2018.
Code Bio
Code Biotherapeutics is an emerging next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to treat serious and life-threatening genetic diseases not well served by other gene therapy technologies.